Search Tag: Chief Medical Officer
2024 25 Jan
Diana Hausman, M.D., Accomplished Oncologist and Drug Developer, Appointed Chief Medical Officer Kyle Rasbach, Ph.D., Pharm.D., Experienced Biotechnology Portfolio Manager, Appointed Chief Business Officer Zentalis ® Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small...Read more
2023 25 Jul
Silver Hill Hospital, one of the nation’s premier psychiatric hospitals, has named Dr. Mark J. Russ, as Chief Medical Officer to oversee clinical operations of its inpatient, transitional living (residential), and outpatient programs. Drawing on 40 years of clinical and leadership experience, Russ will work to enhance Silver Hill Hospital’s programming,...Read more
2023 29 Jun
Bend Health, Inc. ("Bend"), a leading national, virtual pediatric behavioral care provider announced the promotion of Amit Parikh, M.D., to chief medical officer (CMO) in support of its next phase of growth. "As a physician leader, Amit is well-versed in identifying and implementing data-driven solutions that promote patient-centered care for...Read more
2023 20 Jun
Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Vojislav "Vojo" Vukovic as its new Chief Medical Officer (CMO). Dr. Vukovic is an experienced drug development executive with a distinguished career in cancer research and...Read more
2023 14 Jun
Modern Health Continues Momentum With New Research, Key Hires, Product Innovation, and CEO Recognition Modern Health, a leading global workplace mental health platform announced the appointment of Dr. Neha Chaudhary as Chief Medical Officer. A double board-certified child, adolescent, and adult psychiatrist with extensive digital health experience,...Read more
2023 30 May
Inspira Technologies OXY B.H.N. Ltd., a company aiming to revolutionize acute respiratory care, has announced the appointment of Dr. Adi Rizansky Nir, PhD to the position of Chief Medical Officer (“CMO”). Dr. Nir brings a wealth of expertise and a distinguished track record in the field of medicine and healthcare administration to the Company. ...Read more
2023 18 May
Physician-led organization WelbeHealth, the California-based Program of All-Inclusive Care for the Elderly (PACE), announced two industry veterans as its newest executives: Chief Medical Officer, Dr. Michael Le, and Chief Information Officer, Bindu Purushothaman. Both will play a pivotal role as WelbeHealth expands its mission to serve the most vulnerable...Read more
2023 18 May
Bringing expertise in diabetes management medical and regulatory affairs, clinical research, and market access Endogenex, Inc., a clinical stage medical device company, is proud to announce the addition of Christopher Sorli, MD, PhD, as Chief Medical Officer (CMO). Dr. Sorli brings a wealth of experience and clinical expertise to the company’s...Read more
2023 10 May
NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing neuroprotective therapeutics for treating Central Nervous System (CNS) injuries, including stroke and Traumatic Brain Injury announced the expansion of its executive management team with key appointments: Marc de Somer, MD, ScD, MPH, MSc, MBA, has been appointed Chief Medical...Read more
2023 11 Apr
Dr. Mark McKenzie appointed to drive clinical trials at community research sites EmVenio Research announced the appointment of Dr. Mark McKenzie, M.D. as its chief medical officer. In this role, Dr. McKenzie will lead and strategize new initiativs in the clinical and therapeutic areas. He will also provide medical and clinical oversight to EmVenio's...Read more
2023 20 Mar
Ascidian Therapeutics , a biotechnology company focused on treating human diseases by rewriting RNA, announced the appointment of Jay A. Barth , M.D. , as Chief Medical Officer (CMO). With 25 years of experience in drug development and medical affairs, and a focus in gene therapy and rare diseases, Dr. Barth will be responsible for all clinical...Read more
2023 16 Mar
GT Medical Technologies, Inc. has appointed Michael A. Garcia , MD, MS, as its Chief Medical Officer. In his new role, Dr. Garcia will expand the GammaTile ® Therapy clinical study pipeline, support research and development, lead medical affairs, and promote additional efforts for expanding the evidence-based use of GammaTile Therapy and its incorporation...Read more
2023 21 Feb
Medivir AB, a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced that the company’s new Chief Medical Officer (CMO) Pia Baumann took up her position. As member of the company's management team her responsibilities include the continued clinical development of the candidate drug...Read more
2023 04 Jan
Experienced Drug Developer Brings Over 15 Years of Clinical Development Industry Knowledge across Multiple Therapeutic Areas and Modalities BioLineRx Ltd, a pre-commercial-stage biopharmaceutical company focused on oncology announced that it has appointed Tami Rachmilewitz, M.D., as Chief Medical Officer. Dr. Rachmilewitz will report to the CEO...Read more
2022 27 Dec
Dr. Maldonado joins Koya as Chief Medical Officer and member of the Medical Advisory Board Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the addition of Dr. Thomas Maldonado as Chief Medical Officer. The addition of...Read more
2022 15 Dec
Solis Health Plans, a Florida Medicare Advantage Plan, is pleased to announce the appointment of Francisco Hernandez, M.D. as Chief Medical Officer. Dr. Hernandez will join the Solis executive team and be responsible for overseeing clinical operations, care management, quality improvement, pharmacy, health IT, social services, and behavioral health...Read more
2022 15 Dec
Gravie, the leader in health benefits innovation, today announced the hiring of Dr. Greg Burrell as the company's first-ever chief medical officer. Dr. Burrell will serve as the clinical thought leader at Gravie with a focus on improving the quality of healthcare delivered to members, as well as its cost and efficiency. Prior to joining Gravie,...Read more
2022 08 Dec
Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, recently announced that Amily Zhang has been appointed as the Company’s Chief Medical Officer, succeeding Dr. Kevin...Read more
2022 21 Nov
Medivir AB, a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that Pia Baumann has been recruited as its new Chief Medical Officer (CMO). Her role includes overall responsibility for the continued clinical development of the candidate drug fostroxacitabine bralpamide...Read more
2022 16 Nov
The Prostate Cancer Foundation (PCF), the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research announced that William K. Oh, MD, an internationally recognized genitourinary (GU) oncologist with expertise in the use of systemic treatments for prostate cancer, has been appointed Chief Medical Officer...Read more
2022 15 Nov
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, today announced that Linda Neuman, M.D., M.B.A. has been appointed chief medical officer. Dr. Neuman's appointment is an internal promotion from her previous role as Aeglea's...Read more
2022 10 Nov
LiveOnNY, the federally designated organ procurement organization (OPO) for the New York City metropolitan area, Nassau , Suffolk and Westchester counties, and the lower Hudson Valley , announced the appointment of Abraham Warshaw , MD, as Senior Vice President and Chief Medical Officer. Dr. Warshaw is a board-certified emergency medicine...Read more
2022 08 Nov
LumaBridge , (formerly known as Cancer Insight), a clinical research organization (CRO) dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies, welcomes a new chief medical officer, Alexander Stojadinovic, MD, MBA, MSc, FACS. He brings to LumaBridge his extensive experience in strategic planning, program...Read more
2022 02 Nov
Accomplished hematologist-oncologist will provide medical, clinical development, and strategic operational leadership to the ongoing rusfertide Phase 3 development program Protagonist Therapeutics announced the appointment of Arturo Molina, M.D., M.S., F.A.C.P. to the role of Chief Medical Officer, effective November 7, 2022. "We are extremely...Read more
2022 26 Oct
Michael DeLeo, III, M.D., M.B.A., C.P.E., has been named Chief Medical Officer for MelroseWakefield Hospital and Lawrence Memorial Hospital. Dr. DeLeo is a board-certified diagnostic radiologist fellowship trained in breast and oncologic imaging. He is an experienced clinical leader who most recently served as Chief Medical Officer for Foundation...Read more
2022 18 Oct
Cambia Health Solutions is pleased to announce Donna L. Milavetz, MD, MPH, FACP as chief medical officer. She will lead clinical strategy and program design and clinical policy and quality outcomes across the organization. “Since Dr. Milavetz joined Cambia as executive medical director earlier this year, she has established herself as an entrepreneurial...Read more
2022 14 Oct
Sledge to oversee Caris’ Medical Affairs group, bringing over 30 years of oncology research and practice experience to the company Caris Life Sciences ® (Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare announced that George W. Sledge , Jr., M.D....Read more
2022 04 Oct
Dr. Puhlmann has over 20 years of oncology drug development experience and has spearheaded the global development and approval of multiple cancer drugs Viewpoint Molecular Targeting, Inc, a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents announced the...Read more
2022 28 Sep
Experienced emergency physician with a passion for expanding access will enable Avel eCare to continue developing innovative telemedicine solutions that address critical needs across the healthcare industry. Avel eCare, a national leader in delivering clinician-to-clinician telemedicine services, announced the appointment of Kelly Rhone ,...Read more